Assuntos
Fator VII/uso terapêutico , Proteínas Recombinantes/uso terapêutico , Trombastenia/tratamento farmacológico , Perda Sanguínea Cirúrgica/prevenção & controle , Hemorragia/sangue , Hemorragia/tratamento farmacológico , Hemorragia/etiologia , Humanos , Trombastenia/sangue , Resultado do Tratamento , Ferimentos e Lesões/sangue , Ferimentos e Lesões/complicaçõesAssuntos
Fumarato de Formoterol/administração & dosagem , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Tropanos/administração & dosagem , Administração por Inalação , Broncodilatadores/administração & dosagem , Esquema de Medicação , Combinação de Medicamentos , Medicina Baseada em Evidências , Humanos , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Resultado do TratamentoAssuntos
Antiasmáticos/administração & dosagem , Antiasmáticos/uso terapêutico , Asma/tratamento farmacológico , Nebulizadores e Vaporizadores , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Agonistas Adrenérgicos beta/administração & dosagem , Agonistas Adrenérgicos beta/uso terapêutico , Combinação de Medicamentos , Quimioterapia Combinada , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , HumanosRESUMO
The German Pain Association (Deutsche Gesellschaft für Schmerztherapie, DGS) consists of 4800 members, who are physicians of different medical specialties. Their mission is to increase the therapy of chronic pain and to establish it as a combined multidisciplinary treatment. As core requirements of the association the academic education has to be improved, chronic pain to be established as an obligatory subject on the examination for the license to practice medicine. One of the major tasks is to provide continuing medical education for physicians: More than 500 seminars are held by the 150 centers of the German Pain Association.
Assuntos
Clínicas de Dor/estatística & dados numéricos , Dor , Sociedades Médicas , Educação Médica Continuada , Alemanha , Humanos , Medicina , EspecializaçãoRESUMO
Unsafe reprocessing of medical device carries severe health hazards. Definite guidelines for reprocessing were drawn up by the german supreme federal authorities Robert-Koch-Institute (RKI) and Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM). Their joint statement covers both the devices declared for single and multi use. But however, there are problems in safety, resulting from ignorance or non-application of these guidelines especially in the ambulatory/outpatient area. To improve this deficiency, the international expert group for safety in medical device reprocessing (smdr) was founded at the end of 2006 by medical, technical and legal experts from Europe and Asia.
Assuntos
Qualidade de Produtos para o Consumidor/normas , Reutilização de Equipamento/normas , Segurança de Equipamentos/normas , Agências Internacionais/normas , Satisfação do Paciente , InternacionalidadeRESUMO
Founded in 2002, the German Research Network on Neuropathic Pain includes the major institutions, authorities and medical disciplines engaged in therapy and research on Neuropathic pain. Together they work on a better understanding of the pathophysiology, the development of new therapies and the appropriate usage of established interventions for the treatment as well as the prevention of neuropathic pain. The network's central project is the establishment of a data bank, currently including standardized information of more than 1500 patients with neuropathic pain regarding socio-economic, psycho-social, psychological data and the results of quantitative sensory testing (QST), a standardized protocol implemented by the network.